Price History
Market Data
| Market Cap | - |
| Market Cap (USD) | - |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | 1.04 |
| Dividend Yield | - |
| D/E Ratio | 0.33 |
| Current Ratio | 4.09 |
| Market Segment | ChiNext |
| Currency | CNY |
Key Financial Metrics
2.9B
Revenue
512.0M
Net Income
1.04
EPS (Diluted)
348.0M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
19.6%
Net Profit Margin
17.5%
EBITDA
575.0M
Returns & Efficiency
Return on Assets (ROA)
15.2%
Return on Equity (ROE)
20.3%
Dividend Yield
-
EPS
1.04
Financial Health
Total Assets
3.4B
Total Debt
846.0M
Debt to Equity
0.33x
Current Ratio
4.09
Company Info
| Industry | C27医药制造业 |
| Market Segment | ChiNext |
| Currency | CNY |
| Fiscal Year | 2024 |
Peers
2.7T
P/E: 7.6
CHINA CONSTRUCTION BANK
601939
2.5T
P/E: 7.2
AGRICULTURAL BANK OF CHINA
601288
2.4T
P/E: 8.7
CNOOC LIMITED
600938
2.0T
P/E: 16.2
CONTEMPORARY AMPER
300750
1.9T
P/E: 25.6
KWEICHOW MOUTAI
600519
1.8T
P/E: 20.1
BANK OF CHINA LTD
601988
1.8T
P/E: 7.3
CHINA LIFE INSURANCE CO
601628
1.2T
P/E: 6.9
Quick Links
Stock Chart
Open Full Chart View
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
General Information
| Company Name | 九典制药 |
| Ticker | 300705 |
| Exchange | SZSE |
| Sector | 证监会行业分类 |
| Industry | C27医药制造业 |
| Market Segment | ChiNext |
| Fiscal Year | 2024 |
| Currency | CNY |
Financial Summary
| Market Cap | - |
| Revenue | 2.9B |
| Net Income | 512.0M |
| P/E Ratio | - |
| EPS | 1.04 |
| Net Margin | 17.5% |
| ROE | 20.3% |
| Dividend Yield | - |